Welcome to the ValueWiki Provectus Pharmaceutical Inc (PVCT) article! Register for free or click the "edit" link to contribute!    

Provectus Pharmaceutical Inc (PVCT)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Provectus Pharmaceutical Inc? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max




Company Analysis

Provectus Pharmaceutical Inc Snapshot[1]
  • Outstading Shares: 9,452,689 as of 2003-03-21
Provectus Pharmaceutical Inc Contact Information
  • Address: 7327 Oak Ridge Highway Suite A Knoxville, TN 37931 USA
  • Website: http://www.pvct.com
  • Phone: 865-769-4011

News Feed

11/20/08 9:11 am Provectus Lead Investigator Professor John F. Thompson Gives Update on PV-10 Melanoma Study at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting (Business Wire)
11/18/08 6:11 pm Provectus Pharmaceuticals, Inc. The Wall Street Analyst Forum Call Transcript (at Seeking Alpha)
11/18/08 7:11 am Provectus Lead Investigator Professor John F. Thompson to Present at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting on November 19, 2008 (Business Wire)
11/17/08 8:11 am Provectus Pharmaceuticals Adds Sixth Center to Phase 2 Clinical Trial of PV-10 (Business Wire)
11/14/08 9:11 am PROVECTUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
11/04/08 8:11 am Provectus Scheduled to Present at the Rodman & Renshaw 10th Annual Healthcare Conference (Business Wire)
10/31/08 7:10 am Provectus Pharmaceuticals Adds Fifth Center to Phase 2 Clinical Trial of PV-10 (Business Wire)
10/28/08 8:10 am Provectus Announces Completion of Phase 1 Clinical Trial of PV-10 in Recurrent Breast Cancer (Business Wire)
10/20/08 7:10 am Provectus Pharmaceuticals Announces Upcoming Investment Community Events (Business Wire)
10/17/08 9:10 am Provectus Pharmaceuticals Adds Fourth Center to Phase 2 Clinical Trial of PV-10 (Business Wire)
More News...

Leadership

H. Craig Dees, CEO; Timothy C. Scott, President; Daniel R. Hamilton, CFO

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Provectus Pharmaceutical Inc Fundamentals
Provectus Pharmaceutical Inc Technical Analysis
Provectus Pharmaceutical Inc Message Boards

Notes

  1. http://www.pinksheets.com/quote/company_profile.jsp?symbol=PVCT
Personal tools